BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:VET3-TGI readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of VET3-TGI\, from ClinicalTrials.gov estima
 tes.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT06444815-2793@assetmemo.bio
DTSTAMP:20261121T005711Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:VET3-TGI: Phase 1 readout est. (NCT06444815)
DESCRIPTION:VET3-TGI\, phase 1\, Non-Small Cell Lung Cancer.\nStudy: A Stud
 y of VET3-TGI in Patients With Solid Tumors\nEstimated primary completion:
  30 September 2027. This is a ClinicalTrials.gov estimate\, not a confirme
 d readout date\, and it can move.\nDrug page: https://assetmemo.bio/drug/v
 et3-tgi#upcoming-events\nRegistry record: https://clinicaltrials.gov/study
 /NCT06444815
URL:https://assetmemo.bio/drug/vet3-tgi#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
